Effects of smokeless tobacco and tumor promoters on cell population growthand apoptosis of B lymphocytes infected with Epstein-Barr virus types 1 and 2
Hb. Jenson et al., Effects of smokeless tobacco and tumor promoters on cell population growthand apoptosis of B lymphocytes infected with Epstein-Barr virus types 1 and 2, TOX APPL PH, 160(2), 1999, pp. 171-182
The effects of smokeless tobacco purified products 4-(N-methyl-N-nitrosamin
e)-1-3-pyridinyl)-1-butanone (NNK) and N-nitrosonornicotine (NNN), smokeles
s tobacco extracts (dry snuff, moist snuff, and loose leaf), and the tumor
promoters 12-O-tetradecanoyl phorbol-13-acetate (TPA) and n-butyrate on cel
l population growth, cell death, and apoptosis were studied in B lymphocyte
cell lines harboring Epstein-Barr virus (EBV) type 1 (Raji and X50-7) or t
ype 2 (HR-1K and AG876) and in an EBV-uninfected control lymphocyte cell li
ne (Ramos), Spontaneous apoptosis was present in all EBV-infected cell line
s, but at varying levels. Spontaneous and induced apoptosis were generally
greater by Student-Newman-Keuls tests in cells harboring EBV type 2 compare
d to EBV type 1. The greatest effects on cell population growth, cell death
, and apoptosis on cells harboring lytic EBV type 1 (X50-7) was with each o
f the three smokeless tobacco extracts. The greatest effects on cells harbo
ring EBV type 2 was with TPA and n-butyrate. There were no effects of smoke
less tobacco extracts on the Raji cell line that harbors EBV type 1 incapab
le of lytic replication. Smokeless tobacco purified products, NNN and NNK,
had no discernible effects. At the concentrations used in these experiments
, there appears to be an EBV type-specific response to chemical induction,
with greater susceptibility of lytic EBV type 1 to smokeless tobacco extrac
ts and lytic EBV type 2 to TPA and n-butyrate. This EBV type-specific susce
ptibility to the effects of smokeless tobacco extracts is another phenotypi
c difference between EBV types. The use of smokeless tobacco products may a
ffect B lymphocytes infected with replication-capable EBV in the oropharynx
. The absence of significant effects with NNK and NNN suggests that these p
roperties reside with other compounds present in tobacco extracts. (C) 1999
Academic Press.